189 related articles for article (PubMed ID: 35847925)
1. A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma.
Zheng Y; Yue X; Fang C; Jia Z; Chen Y; Xie H; Zhao J; Yang Z; Li L; Chen Z; Bian E; Zhao B
Front Oncol; 2022; 12():930923. PubMed ID: 35847925
[TBL] [Abstract][Full Text] [Related]
2. Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma.
Li L; Yang Z; Zheng Y; Chen Z; Yue X; Bian E; Zhao B
BMC Neurol; 2022 May; 22(1):192. PubMed ID: 35614390
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum stress related IncRNA signature predicts the prognosis and immune response evaluation of uterine corpus endometrial carcinoma.
Chen J; Shen L; Yang Y
Front Oncol; 2022; 12():1064223. PubMed ID: 36686816
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of an Mesenchymal-Related Long Non-Coding RNA Prognostic Model in Glioma.
Huang K; Yue X; Zheng Y; Zhang Z; Cheng M; Li L; Chen Z; Yang Z; Bian E; Zhao B
Front Oncol; 2021; 11():726745. PubMed ID: 34540695
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression.
Yang Z; Zheng Y; Wu H; Xie H; Zhao J; Chen Z; Li L; Yue X; Zhao B; Bian E
Hum Genomics; 2023 Mar; 17(1):33. PubMed ID: 37004060
[TBL] [Abstract][Full Text] [Related]
7. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
Xiang Z; Chen X; Lv Q; Peng X
Front Genet; 2021; 12():697819. PubMed ID: 34408772
[TBL] [Abstract][Full Text] [Related]
8. An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis.
Wang X; Gao M; Ye J; Jiang Q; Yang Q; Zhang C; Wang S; Zhang J; Wang L; Wu J; Zhan H; Hou X; Han D; Zhao S
Front Genet; 2020; 11():612037. PubMed ID: 33391355
[TBL] [Abstract][Full Text] [Related]
9. Development of an Immune-Related LncRNA Prognostic Signature for Glioma.
Cao Y; Zhu H; Tan J; Yin W; Zhou Q; Xin Z; Wu Z; Jiang Z; Guo Y; Kuang Y; Li C; Zhao M; Jiang X; Peng J; Ren C
Front Genet; 2021; 12():678436. PubMed ID: 34194477
[TBL] [Abstract][Full Text] [Related]
10. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
11. Identification and Validation of an Endoplasmic Reticulum Stress-Related lncRNA Signature for Colon Adenocarcinoma Patients.
Chen X; Gao K; Xiang Z; Zhang Y; Peng X
Int J Gen Med; 2022; 15():4303-4319. PubMed ID: 35480990
[TBL] [Abstract][Full Text] [Related]
12. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
Xia P; Li Q; Wu G; Huang Y
Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of drug sensitivity, immunological characteristics, and prognosis in melanoma patients using an endoplasmic reticulum stress-associated signature based on bioinformatics and pan-cancer analysis.
Hounye AH; Hu B; Wang Z; Wang J; Cao C; Zhang J; Hou M; Qi M
J Mol Med (Berl); 2023 Oct; 101(10):1267-1287. PubMed ID: 37653150
[TBL] [Abstract][Full Text] [Related]
14. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
16. A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma.
Cheng M; Sun L; Huang K; Yue X; Chen J; Zhang Z; Zhao B; Bian E
Front Oncol; 2021; 11():646409. PubMed ID: 33828990
[TBL] [Abstract][Full Text] [Related]
17. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an endoplasmic reticulum stress-related signature to evaluate immune features and predict prognosis in glioma.
Zhang Q; Guan G; Cheng P; Cheng W; Yang L; Wu A
J Cell Mol Med; 2021 Apr; 25(8):3870-3884. PubMed ID: 33611848
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatic Analyses Identify a Prognostic Autophagy-Related Long Non-coding RNA Signature Associated With Immune Microenvironment in Diffuse Gliomas.
Xu S; Tang L; Liu Z; Yang K; Cheng Q
Front Cell Dev Biol; 2021; 9():694633. PubMed ID: 34211979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]